Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 2Sarcoma 1Prostatic Neoplasms 1Primary Care 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

Psychiatric Rehabilitation 3Early Intervention, Educational 3Carboplatin 3Behavior Therapy 3Surgical Procedures, Operative 2Specimen Handling 2Platinum 2Palliative Care 2Methods 2Hyperthermic Intraperitoneal Chemotherapy 2Gene Expression Profiling 2Cisplatin 2Blood Specimen Collection 2taxane 1oregovomab 1motexafin lutetium 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Touch 1Taxes 1Standard of Care 1Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1Sodium Chloride 1Serotonin Plasma Membrane Transport Proteins 1Radiotherapy 1Propranolol 1Preoperative Exercise 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Fallopian Tube Neoplasms × Darbepoetin alfa × Clear all
NCT06184867 2026-03-06

CATALYST

Rutgers, The State University of New Jersey

Phase NA Completed
50 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡